Andersons pediatric cardiology 1675
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.23 KB, 3 trang )
193.YangCF,YangCC,LiaoHC,etal.Veryearly
treatmentforInfantile-onsetpompedisease
contributestobetteroutcomes.JPediatr.
2016;169:174–180e171.
194.MaronBJ,GottdienerJS,BonowRO,Epstein
SE.Hypertrophiccardiomyopathywithunusual
locationsofleftventricularhypertrophy
undetectablebyM-modeechocardiography.
Identificationbywide-angletwo-dimensional
echocardiography.Circulation.1981;63(2):409–
418.
195.MaronBJ,BonowRO,SeshagiriTN,Roberts
WC,EpsteinSE.Hypertrophiccardiomyopathy
withventricularseptalhypertrophylocalizedto
theapicalregionoftheleftventricle(apical
hypertrophiccardiomyopathy).AmJCardiol.
1982;49(8):1838–1848.
196.YamaguchiH,IshimuraT,NishiyamaS,etal.
Hypertrophicnonobstructivecardiomyopathy
withgiantnegativeTwaves(apical
hypertrophy):ventriculographicand
echocardiographicfeaturesin30patients.AmJ
Cardiol.1979;44(3):401–412.
197.ShapiroLM,McKennaWJ.Distributionofleft
ventricularhypertrophyinhypertrophic
cardiomyopathy:atwo-dimensional
echocardiographicstudy.JAmCollCardiol.
1983;2(3):437–444.
198.MaronMS,HauserTH,DubrowE,etal.Right
ventricularinvolvementinhypertrophic
cardiomyopathy.AmJCardiol.
2007;100(8):1293–1298.
199.KwonDH,SetserRM,ThamilarasanM,etal.
Abnormalpapillarymusclemorphologyis
independentlyassociatedwithincreasedleft
ventricularoutflowtractobstructionin
hypertrophiccardiomyopathy.Heart.
2008;94(10):1295–1301.
200.MinakataK,DearaniJA,NishimuraRA,Maron
BJ,DanielsonGK.Extendedseptalmyectomy
forhypertrophicobstructivecardiomyopathy
withanomalousmitralpapillarymusclesor
chordae.JThoracCardiovascSurg.
2004;127(2):481–489.
201.HarriganCJ,AppelbaumE,MaronBJ,etal.
Significanceofpapillarymuscleabnormalities
identifiedbycardiovascularmagneticresonance
inhypertrophiccardiomyopathy.AmJCardiol.
2008;101(5):668–673.
202.KluesHG,RobertsWC,MaronBJ.Anomalous
insertionofpapillarymuscledirectlyinto
anteriormitralleafletinhypertrophic
cardiomyopathy.Significanceinproducingleft
ventricularoutflowobstruction.Circulation.
1991;84(3):1188–1197.
203.SchantzD,BensonL,WindramJ,etal.
Abnormalmitralvalvedimensionsinpediatric
patientswithhypertrophiccardiomyopathy.
PediatrCardiol.2016;37(4):784–788.
204.SorajjaP,OmmenSR,NishimuraRA,etal.
Myocardialbridginginadultpatientswith
hypertrophiccardiomyopathy.JAmColl
Cardiol.2003;42(5):889–894.
205.YetmanAT,McCrindleBW,MacDonaldC,
FreedomRM,GowR.Myocardialbridgingin
childrenwithhypertrophiccardiomyopathy–a
riskfactorforsuddendeath.NEnglJMed.
1998;339(17):1201–1209.
206.MohiddinSA,BegleyD,ShihJ,FananapazirL.
Myocardialbridgingdoesnotpredictsudden
deathinchildrenwithhypertrophic
cardiomyopathybutisassociatedwithmore
severecardiacdisease.JAmCollCardiol.
2000;36(7):2270–2278.
207.BassoC,ThieneG,Mackey-BojackS,etal.
Myocardialbridging,afrequentcomponentof
thehypertrophiccardiomyopathyphenotype,
lackssystematicassociationwithsuddencardiac
death.EurHeartJ.2009;30(13):1627–1634.
208.KunkalaMR,SchaffHV,BurkhartH,etal.
Outcomeofrepairofmyocardialbridgingatthe
